This patent will specifically protect Cytori’s Celution System-based devices and methods essential in novel cosmetic and reconstructive surgery procedures.
According to Cytori, this is an important development for the company because it creates a stronger barrier-to-entry against potentially competitive methods specifically within the cosmetic and reconstructive surgery market and protects in the US, a product currently on sale in many countries around the world.
The methods and devices covered by this patent may be useful to protect products treating a variety of clinical applications beyond breast reconstruction such as the general repair of soft tissue defects, breast augmentation, facial reconstruction and augmentation, vocal cord repair, soft tissue defects secondary to radiation therapy as well certain urologic and gastrointestinal conditions.